Arbor Pharmaceuticals Announces FDA Approval of First NDA
5/14/2013 9:16:35 AM
More...
|
Eisai Inc. (ESALF.PK) Divests U.S. Rights for GLIADEL® Wafer (Polifeprosan 20 With Carmustine Implant) to Arbor Pharmaceuticals
12/17/2012 9:12:38 AM
More...
|
Thom Rowland Joins Arbor Pharmaceuticals as Vice President of Commercial Operations
11/7/2012 9:38:56 AM
More...
|
Arbor Pharmaceuticals Partners with the Association of Black Cardiologists to Further the Campaign of "Saving Hearts of a Diverse America"
7/10/2012 11:35:11 AM
More...
|
Arbor Pharmaceuticals Release: New Hospitalization Data from the African-American Heart Failure Trial to be Presented at the American College of Cardiology's 2012 Scientific Session
3/27/2012 9:01:04 AM
More...
|
Leslie Zacks Joins Arbor Pharmaceuticals as General Counsel and Chief Compliance Officer
2/21/2012 12:01:53 PM
More...
|
Arbor Pharmaceuticals’s Edward Schutter, Emory University President James Wagner To Receive 2012 GaBio Industry Growth Awards
12/22/2011 10:54:19 AM
More...
|
Arbor Pharmaceuticals Announces Filing of First NDA
12/1/2011 12:40:10 PM
More...
|
Arbor Pharmaceuticals Completes $34.8 Million Financing
11/12/2010 6:25:04 AM
More...
|
Laurence J. Downey, MD Joins Arbor Pharmaceuticals as Vice President of Medical Affairs
10/27/2010 11:24:31 AM
More...
|
|